Omalizumab added to allergen immunotherapy increased the effect of therapy in patients with severe local allergic rhinitis.
Andrzej BozekRenata KozłowskaMaciej MisiołekWojciech ŚcierskiRadosław GawlikPublished in: Human vaccines & immunotherapeutics (2022)
Omalizumab may be a valuable treatment that increases the effectiveness of immunotherapy in patients with severe LAR.